Baldwin Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Baldwin Investment Management's LLY Position: Q2 2026 in Review
Baldwin Investment Management increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $2.06M and bringing the position to 12,959 shares worth $15.5M. The position accounts for 1.5% of the portfolio, ranked #9.
Baldwin Investment Management first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Baldwin Investment Management held 12,959 shares of Eli Lilly worth $15.5M as of Q2 2026.
- Baldwin Investment Management bought 2,019 Eli Lilly shares in Q2 2026, an estimated $2.06M.
- Eli Lilly made up 1.5% of Baldwin Investment Management's portfolio in Q2 2026, its #9 holding.
- Baldwin Investment Management first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Baldwin Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.